銀邦股份(300337.SZ):銀邦防務擬對控股子公司黎陽天翔增資
格隆匯 8 月 20日丨銀邦股份(300337.SZ)公告,公司全資子公司無錫銀邦防務科技有限公司(以下簡稱“銀邦防務”)2020年8月20日與公司控股子公司貴州黎陽天翔科技有限公司(以下簡稱“黎陽天翔”)其他股東鄭登強、柴國均簽訂《貴州黎陽天翔科技有限公司之增資協議》,約定按照現有持股比例進行同比例增資,增資後黎陽天翔的註冊資本由人民幣1333.33萬元增至2.68億元,出資期限為增資協議生效後3年。各增資方應在出資期限到期之日前將本次認繳增資金額實繳到位。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.